The Daily Northwestern

FDA details potential plan to grant accelerated approval to Duchenne treatment

Rebecca Savransky, Campus Editor

April 22, 2014

Filed under Campus, Dance Marathon 2014, Latest Stories

The Food and Drug Administration outlined a possible pathway that would grant accelerated approval to a drug with the potential to treat Duchenne muscular dystrophy, the disease Dance Marathon raised more than $1.3 million to fu...